α1-receptors at pre-capillary resistance vessels of the human nasal mucosa

Rhinology

Volumn 35, Issue 4, 1997, Pages 161-165

  Johannssen, V ^a   Maune, S ^a   Werner, J A ^a   Rudert, H ^a   Ziegler, A ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

adrenoceptor blockers; 1 adrenoceptor; Catecholamines; Human nasal mucosa

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CARBACHOL; CORTISONE; DECONGESTIVE AGENT; GLYCERYL TRINITRATE; NORADRENALIN; OXYMETAZOLINE; PHENYLEPHRINE; POTASSIUM CHLORIDE; PRAZOSIN; RECEPTOR SUBTYPE; YOHIMBINE;

ADULT; AEROSOL; AGED; ARTERY DIAMETER; ARTICLE; CAPACITANCE BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MALE; NOSE MUCOSA; RESISTANCE BLOOD VESSEL; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; ARTERIOLES; CARBACHOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL MUCOSA; NOREPINEPHRINE; OXYMETAZOLINE; PHENYLEPHRINE; POTASSIUM; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; VASOCONSTRICTION; YOHIMBINE;

EID: 0031406882     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Abdel-Latif AA (1986) Calcium-mobilizing receptors, polyphosphoinositides and the generation of second messengers. Pharmacol Rev 38: 227-272.
2. Andersson KE, Bende M (1984) Adrenoreceptors in the control of human nasal mucosal blood flow. Ann Otol Rhinol Laryngol 93: 179-182.
3. Bende M (1983) The effect of topical decongestant on blood flow in normal and infected nasal mucosa. Acta Otolaryngol (Stockh) 96: 523-527.
4. Bende M, Löth S (1986) Vascular effects of topical oxymetazoline on human nasal mucosa. J Laryngol Otol 100: 285-288.
5. Berridge MJ, Irvine RF (1984) Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315-321.
6. 1-adrenoceptors in the vasculature of the canine nasal mucosa. Br J Pharmacol 88: 345-354.
7. Chand N, Altura BM (1981) Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: Role in lung vascular diseases. Science 213: 1376-1379.
8. Cherry PD, Furchgott RF, Zawadski JV, Johinadan D (1982) Role of endothelial cells in relaxation of isolated arteries by bradykinin. Physiolog Sciences 79: 2106-2110.
9. Chuang DM (1989) Neurotransmitter receptors and phosphoinositide turnover. Ann Rev Pharmacol Toxicol 29: 71-110.
10. Exton JH (1985) Mechanisms involved in α-adrenergic phenomena. Am J Physiol 248: 663-647.
11. Furchgott RF (1990) Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol Scand 139: 257-270.
12. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
13. Geiger J, Nolte C. Butt E. Sage SO, Walter U (1992) Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist evoked calcium elevation in human platelets. Proc Natl Acad Sci (USA) 89: 1031-1035.
14. Gerold M, Haesler G (1983) Alpha-2-adrenoceptors in rat resistance vessels. Naunyn-Schmiedeberg's Arch Pharmacol 322: 29-33.
15. Hashimoto T, Hirata M, Itoh T. Kanmura Y, Kariyama H (1986) Inositol-1,4,5-triphosphate activates pharmacomechanical coupling in smooth muscle. J Physiol (London) 370: 605-612.
16. Hinke JAM, Wilson ML, Burnham SC (1964) Calcium and the contractility of vascular smooth muscle. Am J Physiol 206: 211-217.
17. 2-adrenoceptors in blood vessels of human nasal mucosa. Arch Otorhinolaryngol 245: 127-131.
18. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chauddhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxid. Proc Natl Acad Sci (USA) 84: 9265-9269.
19. Komori K, Suzuki H (1987) Heterogeneous distribution of muscarinic receptors in the rabbit saphenous artery. Br J Pharmacol 92: 657-664.
20. Lacroix JS (1989) Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand 329: 1-63.
21. Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circulation Res 41: 19-26.
22. Nielsen H, Mulvany MJ (1990) The divergence in the excitation-contraction coupling of rat mesenteric resistance arteries lies distal to the receptor site. Eur J Pharmacol 170: 1-7.
23. Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665.
24. Rosatti B (1953) Ueber die Blutzirkulation und die arteriovenösen Anastomosen der menschlichen Nasenschleimhaut. Anat Anz 100: 243-247.
25. Starke K, Endo T, Taube HD (1975) Relative pre- and postsynaptic potencies of α-adrenoceptors agonist in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291: 55-78.
26. Somylo AP (1985) Excitation-contraction coupling and the ultrastructure of smooth muscle. Circulation Res 57: 497-507.
27. Vanhoutte PM, Miller VM (1985) Heterogeneity of endothelium-dependent responses in mammalian blood vessels. J Cardiovasc Pharmacol 7 (Suppl 3): 12-23.
28. Van Bibber R, Traub O, Kroll K, Feigl EO (1995) EDRF and norepinephrine-induced vasodilation in the canine coronary circulation. Am J Physiol 268: 1973-1981.
29. 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol 69: 205-208.
30. 2-receptors and their mechanisms of action. Acta Physiol Scand 468: 1-99.
31. Wilson C, Cooper SM, Buckingham RE, Clapham JC (1987) Alpha-1-adrenoceptor-mediated contraction of rabbit mesenteric artery: A role for intra- and extracellular calcium pools. J Cardiovasc Pharmacol 9: 401-406.
32. Zuckerkandl E (1885) Pathologische und normale Anatomie der Nasenhöhle. Denkschr Kais Akad Wiss 49: 121.